GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
21:21 Sep 22, 2020 |
English to Croatian translations [PRO] Medical - Medical: Pharmaceuticals / Clinical trial | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Lirka Austria Local time: 14:11 | ||||||
Grading comment
|
Summary of answers provided | ||||
---|---|---|---|---|
4 +1 | Biološki temeljni antireumatici, koji ne inhibiraju TNF |
| ||
3 +1 | biološki DMARD-ovi koji ne inhibiraju TNF |
|
Discussion entries: 4 | |
---|---|
non-tnf inhibiting biologic dmards Biološki temeljni antireumatici, koji ne inhibiraju TNF |
| |
Grading comment
| ||
Login to enter a peer comment (or grade) |
non-tnf inhibiting biologic dmards biološki DMARD-ovi koji ne inhibiraju TNF Explanation: (MTX) je najčešće prvi lijek izbora među lijekovima koji mijenjaju tijek bolesti (engl. di- sease modifying anfi-rheumafic drugs; DMARD) https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&c... Ili: biološki lijekovi koji mijenjaju tijek bolesti i ne inhibiraju faktor nekroze tumora Ufff... :-D -------------------------------------------------- Note added at 11 hrs (2020-09-23 08:23:36 GMT) -------------------------------------------------- Lijekovi koji modificiraju tijek bolesti (DMARD) se uobičajeno dijele u dvije kategorije: konvencionalne (sintetske, nebiološke) i biološke. https://www.cybermed.hr/clanci/lijecenje_trajno_aktivnog_reu... ... aktivnu bolest unatoč liječenju s jednim ili više nebioloških DMARD-ova, koji se primjenjuju ... ... aktivnu bolest unatoč liječenju s jednim ili više nebioloških DMARD-ova, koji se primjenjuju ... -------------------------------------------------- Note added at 11 hrs (2020-09-23 08:24:05 GMT) -------------------------------------------------- https://repozitorij.pharma.unizg.hr/islandora/object/pharma:... |
| |
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.